Medical Device Chemistry

Over the last decade, the medical device market more than ever has relied on new chemistries, particularly with respect to new drug-device combinations. Emerging companies needing to differentiate their novel technologies increasingly depend on specialized chemistry. Advances in medical devices with chemical components require the expertise of highly-skilled synthetic and analytical chemists in organic, polymer or inorganic chemistry. Potential outsourcing partners must possess a complex understanding of cGMP quality standards and other compliance regulations related to pre-clinical, first-in-man studies or full validation testing.

Frequently, medical device companies lack sufficient chemistry-focused human capital, despite the aforementioned trend in product development. Fortunately they can enlist Richman Chemical as their primary CRO/CMO partner to evaluate the technology, optimize scale-up and ensure compliant full-scale manufacturing. This high level of expertise in the polymer and inorganic areas serves the medical device space quite well, complementing our traditional strength in the field of multi-step, synthetic organic chemistry.

Richman Chemical meets the outsourcing challenges of medical device clients in numerous ways, including research and development, validated pilot manufacturing, clinical batch manufacturing, and cGMP-compliant commercial production.  Please contact us to see how we can accelerate your commercialization timeline!